Ewelina Madej

8PUBLICATIONS
53CO-AUTHORS
Molecular targetsHaematological tumoursAutoimmunityPlant developmental and reproductive biologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 09, 2026
RIPK4 function interferes with melanoma cell adhesion and metastasis.

Norbert Wronski, Sławomir Lasota, Ewelina Madej

|Nov 07, 2025
Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.

K S Kurz, A Zamo, C Drewes

|Mar 26, 2025
Breast implant associated anaplastic large-cell lymphoma: a latent relapse as peritoneal and pleural effusion.

Ewelina Madej, Vishakha Sovani, Malee Fernando

|Jan 08, 2025
RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis.

Bartlomiej Olajossy, Norbert Wronski, Ewelina Madej

|Dec 26, 2024
Primary thyroid B-cell lymphoma: molecular insights into its clonal evolution and relapse.

Maria-Myrsini Tzioni, Natsuko Watanabe, Zi Chen

|Nov 11, 2024
Multi-neoplastic potentials including metachronous clonally unrelated nodal T-follicular helper cell lymphomas in clonal haematopoiesis.

Ayoma D Attygalle, Pui Kwan Chak, Ewelina Madej

Pageof 2

Frequent Collaborators

4 joint publications

Ming-Qing Du

3 joint publications

Agnieszka Wolnicka-Glubisz

3 joint publications

Zi Chen

2 joint publications

Ayoma D Attygalle